154
Participants
Start Date
December 6, 2019
Primary Completion Date
March 14, 2022
Study Completion Date
June 1, 2022
IVM w/ ALB
Participants will be given a single dose of oral IVM (150 µg/kg) plus ALB (400 mg) (IVM/ALB)
Single dose of IDA
Participants will be given a single dose of oral IVM (150 µg/kg), DEC (6 mg/kg) and ALB (400 mg)
Three daily doses of IDA
Participants will be given one daily dose for 3 days of oral IVM (150 µg/kg), DEC (6 mg/kg) and ALB (400 mg)
University of Health and Allied Sciences, Hohoe
Case Western Reserve University
OTHER
University of Health and Allied Sciences
OTHER
Washington University School of Medicine
OTHER